Salus Science Corporation Notice regarding the research that Keisuke Taniuchi, CEO of our company, is working on at Kochi University. | サルスサイエンス株式会社

NEWS

Notice regarding the research that Keisuke Taniuchi, CEO of our company, is working on at Kochi University.

The “Implementation Plan for Non-Clinical Safety Study of Nucleic Acid Preparation for Pancreatic Cancer” (Principal Investigator: Associate Professor Keisuke Taniuchi, Department of Clinical Medicine, Kochi University), which was submitted by Nippon Shokubai Co. The details are available on the website of Kochi University.

Go to Kochi University Information Page

Back To List